Novel test holds promise for detecting Parkinson’s disease early
Novel Test Holds Promise for Detecting Parkinson’s Disease Early
Investigators from Brigham and Women’s Hospital and the Wyss Institute are working together to develop a new approach to detect and quantify minute amounts of a biomarker of Parkinson’s disease and related disorders at early stages
The platform has the potential to create early applicable molecular diagnostics, improve clinical trials, and facilitate drug screening
(Boston) — In the development of Parkinson’s ...













